Skip to Main Content Skip to Main Content

HSC Medicine, Dentistry and Healthcare Sciences Current Awareness Bulletins: Diabetes and Endocrinology

Diabetes and Endocrinology current awareness bulletin

Frequency: Bi-monthly

Links to articles in the current and previous 2 issues of this bulletin are displayed below.

To receive email notifications about new issues of this bulletin, please email richard.fallis@healthcarelibrary.qub.ac.uk to subscribe.

May 2024

Adequacy of thyroid hormone replacement for people with hypothyroidism in real-world settings 10.1111/cen.14998

Atypical diabetes: what have we learned and what does the future hold? 10.2337/dci23-0038

Beyond the bias! Sex distribution in paediatric growth hormone deficiency reexamined 10.1111/cen.15047  

Clinical and immunological characteristics of children diagnosed with—type 1 diabetes during the COVID-19 pandemic 10.1111/dme.15250

Diabetic complications and risk of depression and anxiety among adults with type 2 diabetes 10.1111/dme.15272  

Emotional distress predicts reduced type 2 diabetes treatment adherence in the glycemia reduction approaches in diabetes 10.2337/dc23-1401

Evaluation of quality of life in children with precocious puberty 10.1111/cen.15033  

The Fusion Clinic: integrating the care of people with severe mental illness and diabetes 10.1111/dme.15255  

Healthcare and research priorities for women with polycystic ovary syndrome in the UK National Health Service 10.1111/cen.15038  

Identifying preferred features of weight loss programs for adults with or at risk of type 2 diabetes: a discrete choice experiment with 3,960 adults in the UK 10.2337/dc23-2019

The impact of stigma on the management of type 1 diabetes: a systematic review 10.1111/dme.15299  

Initial surgical management of sporadic medullary thyroid cancer 10.1111/cen.15041  

Optimising glycaemic control in people with type 1 diabetes (new SIGN guideline 170)

Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID-19 10.1111/cen.15012  

Point-of-care HbA1c in clinical practice: caveats and considerations for optimal use 10.2337/dci23-0040

Roles and competencies of the clinical psychologist in adult diabetes care—a consensus report 10.1111/dme.15312  

Socioeconomic deprivation and the risk of sight-threatening diabetic retinopathy (STDR): a population-based cohort study in the UK 10.2337/dc23-1626

Steroidogenic acute regulatory protein (STAR) deficiency: our experience and systematic review for phenotype–genotype correlation 10.1111/cen.15032  

Tyrosine kinase inhibitors for radioiodine refractory differentiated thyroid cancer 10.1111/cen.15027

Sources

Clinical Endocrinology (Apr-May); Diabetes Care (Apr); Diabetic Medicine (Apr-May); SIGN website (Mar)

March 2024

Application of CRISPR-Cas9 technology in diabetes research 10.1111/dme.15240  

Comparing the glycaemic outcomes between real-time continuous glucose monitoring (rt-CGM) and intermittently scanned continuous glucose monitoring (isCGM) among adults and children with type 1 diabetes 10.1111/dme.15280  

Effects of different insulin sensitisers in the management of polycystic ovary syndrome 10.1111/cen.14983

Estimating the cost-effectiveness of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in England 10.1111/dme.15232  

Gestational diabetes: One size does not fit all—an observational study of maternal and neonatal outcomes by maternal glucose profile 10.1111/dme.15205  

Hospital admissions among people with diabetes 10.1111/dme.15236  

Impact of radioiodine therapy on recurrence and survival outcomes in intermediate-risk papillary thyroid carcinoma 10.1111/cen.15001

Inequalities in the management of diabetic kidney disease in UK primary care 10.1111/dme.15153  

Intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: A subgroup analysis from the FLASH-UK study 10.1111/dme.15249  

Lymph node imaging for thyroid cancer 10.1111/cen.14993  

Managing adults with hypoglycemia 10.1016/j.annemergmed.2023.07.019

New advances in type 1 diabetes 10.1136/bmj-2023-075681

Men, testosterone and COVID-19 10.1111/cen.14952  

Outcomes measured in studies assessing health systems interventions for type 1 diabetes management 10.1111/dme.15223  

The psychosocial burdens of living with diabetes 10.1111/dme.15219

Surgical and non‐surgical interventions for primary and salvage treatment of growth hormone‐secreting pituitary adenomas in adults 10.1002/14651858.CD013561.pub2

Systematic review of guidelines on neonatal hypoglycemia 10.1111/cen.14995

Telemedicine in the treatment of gestational diabetes 10.1111/dme.15201  

A UK national survey of enteral feed use in people with diabetes 2022 10.1111/dme.15216  

The use of prednisolone during Ramadan fasting in patients with adrenal insufficiency 10.1111/cen.14999

Sources

Annals of Emergency Medicine (Dec); BMJ (26th Jan); Clinical Endocrinology (Jan-Mar); Cochrane Library (Jan-Feb); Diabetic Medicine (Jan-Mar)

January 2024

Associations between maternal gestational diabetes metformin or insulin treatment and offspring growth trajectories from birth to 60 months of age: Findings from the Born in Bradford (BiB) study DOI: 10.1111/dme.15204

Biological variation in thyroid function tests in older adults and clinical implications DOI: 10.1111/cen.14973

Clinical profile and treatment outcomes among patients with sporadic and multiple endocrine neoplasia syndrome-related primary hyperparathyroidism DOI: 10.1111/cen.14945

The dangerous trend of levothyroxine medicalization DOI: 10.1016/j.tem.2023.08.017

Diabetes prevention at scale: Narrative review of findings and lessons from the DIPLOMA evaluation of the NHS Diabetes Prevention Programme in England DOI: 10.1111/dme.15209

Genome-wide association study of thyroid-stimulating hormone highlights new genes, pathways and associations with thyroid disease DOI: 10.1038/s41467-023-42284-5

The impact of diabetes and obesity on fertility and the potential role of gut hormones as treatment DOI: 10.1111/dme.15230

The journey towards implementation of the NHS Diabetes Prevention Programme: A personal perspective DOI: 10.1111/dme.15191

Macronutrient intake in children and adolescents with type 1 diabetes and its association with glycemic outcomes DOI: 10.1155/2023/7102890

Pregnancy, delivery and neonatal outcomes among women with hypoparathyroidism—A population-based study DOI: 10.1111/cen.14969

Pre-polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set DOI: 10.1111/cen.14964

Prevalence and associated factors of sexual dysfunction in premenopausal women with type 1 diabetes: A systematic review and meta-analysis DOI: 10.1111/dme.15173

Real world evidence supports waking salivary cortisone as a screening test for adrenal insufficiency DOI: 10.1111/cen.14975

Road map for personalized exercise medicine in T2DM DOI: 10.1016/j.tem.2023.08.013

Trends in incidence of ischaemic stroke in people with and without diabetes in Ireland 2005–2015 DOI: 10.1111/dme.15127

Type 1 diabetes in the pancreas: A histological perspective DOI: 10.1111/dme.15228

Wearable digital health technologies in medicine: digital technology for diabetes (review) DOI: 10.1056/NEJMra2215899

What can functional brain imaging teach us about remission of type 2 diabetes? DOI: 10.1111/dme.15235

Sources used: Clinical Endocrinology (Nov, Dec); Diabetic Medicine (Nov, Dec); Nature Communications (Oct); NEJM (30th Nov); Pediatric Diabetes (Nov); Trends in Endocrinology and Metabolism (Dec)